Heart Failure/complications; Pulmonary Disease, Chronic Obstructive/complications; Aged; Aged, 80 and over; Chronic Disease; Cohort Studies; Female; Forced Expiratory Volume; Humans; Male; Middle Aged; Prevalence; Pulmonary Disease, Chronic Obstructive/diagnosis; Pulmonary Disease, Chronic Obstructive/epidemiology; Risk Factors; Spirometry; Vital Capacity

ABHR; ACE-I; ARB; ATS/ERS; American Thoracic Society/European Respiratory Society; BMI; CABG; COPD; CRT; CS; Chronic heart failure; Chronic obstructive pulmonary disease; FEV(1)/FVC; FS; Fixed ratio; GOLD; Global Initiative for Chronic Obstructive Lung Disease; HF; ICD; LLN; LVEF; LVSD; Lower limit of normal; MLHFQ; MRC; Minnesota Living with Heart Failure Questionnaire; N-terminal pro-B natriuretic peptide; NS; NT-pro-BNP; NYHA; New York Heart Association; PCI; PFT; PY; Prevalence; angiotensin receptor blocker; angiotensin-converting enzyme inhibitor; aspecific bronchial hyperreactivity; body mass index; cardiac resynchronization therapy; chronic obstructive pulmonary disease; coronary artery bypass grafting; current smokers; former smokers; heart failure; implantable cardioverter defibrillator; left ventricular ejection fraction; left ventricular systolic dysfunction; lower limit of normal; modified Medical Research Council dyspnea scale; non-smokers; pack-years; percutaneous coronary intervention; pulmonary function tests; ratio of forced expiratory volume in 1 s to forced vital capacity